N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide(CAS: 103177-37-3)

N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide is a crystalline compound with a high molecular weight. It has moderate solubility in common organic solvents and poor solubility in water. The compound is reactive towards nucleophiles and can undergo substitution reactions. It has a melting point around 180-185°C and a density of approximately 1.35 g/cm³.

N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide can be synthesized via a multi-step process involving cyclization, condensation reactions, and derivatization. Common catalysts include palladium(II) acetate and triphenylphosphine. The synthesis typically achieves yields of 70-80%, with good selectivity towards the desired product.

N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide is used in the pharmaceutical industry for its potential as an intermediate in drug synthesis. It is also utilized in the semiconductor industry due to its electronic properties, and in polymer applications for its structural stability. Additionally, it can be employed in sensor technology for specific detection applications.

When handling N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide, protective equipment such as gloves, goggles, and a lab coat should be worn. It should be handled in a well-ventilated area or fume hood to avoid inhalation. Spills should be cleaned up using appropriate absorbent materials and disposed of according to local regulations. The Safety Data Sheet (SDS) should be consulted for detailed handling and disposal information.